Genetic Risk Classifier to Predict Localised Renal Cell Carcinoma Recurrence

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(19)30234-7
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

BPDE-INDUCED LYMPHOCYTIC CHROMOSOME 3p DELETIONS MAY PREDICT RENAL CELL CARCINOMA RISK

Journal of Urology
Urology
2008English

Single Nucleotide Polymorphisms and Risk of Recurrence of Renal-Cell Carcinoma: A Cohort Study

The Lancet Oncology
Oncology
2013English

Molecular Genetic Diagnostics of Clear Cell Renal Cell Carcinoma

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2016English

Endogenous Retroviral Signatures Predict Immunotherapy Response in Clear Cell Renal Cell Carcinoma

Journal of Clinical Investigation
Medicine
2018English

A Whole Slide Image-Based Machine Learning Approach to Predict Ductal Carcinoma in Situ (DCIS) Recurrence Risk

Breast Cancer Research
Cancer ResearchOncology
2019English

Intensive Imaging-Based Follow-Up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-Recurrence Survival: Results From a European Multicentre Database (RECUR)

European Urology, Supplements
Urology
2019English

Local Recurrence of Renal Cell Carcinoma Presented With Massive Gastrointestinal Bleeding: Management With Renal Artery Embolization

CVIR Endovascular
2019English

Widespread Molecular Alterations Present in Stage I Non-Small Cell Lung Carcinoma Fail to Predict Tumor Recurrence

Modern Pathology
Forensic MedicinePathology
2003English

Variants ofSCARB1andVDRInvolved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy